GHTC Breakthroughs Blog

Research Roundup: FDA approves monthly injectable HIV treatment, US recommits to WHO and joins COVAX, and Eli Lilly says antibody can prevent COVID-19 infection

PATH/Evelyn Hockstein

January 25, 2021

Research Roundup: FDA approves monthly injectable HIV treatment, US recommits to WHO and joins COVAX, and Eli Lilly says antibody can prevent COVID-19 infection

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC

Quiz: Test your knowledge of NTD innovation

GHTC

January 21, 2021

Quiz: Test your knowledge of NTD innovation

How much do you know about combatting neglected tropical diseases? In recognition of World NTD Day on January 30, GHTC is testing our readers' knowledge of NTD innovation.

Anna Kovacevich GHTC

Research Roundup: J&J releases interim vaccine data, African Union secures 270 million vaccine doses, and experts affirm need for next-generation vaccines

PATH/Matthew Dakin

January 19, 2021

Research Roundup: J&J releases interim vaccine data, African Union secures 270 million vaccine doses, and experts affirm need for next-generation vaccines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC

Research Roundup: NIAID begins new antibody trials, convalescent plasma may lower COVID-19 risk, and Pfizer vaccine appears effective against mutation

PATH/Eric Becker

January 11, 2021

Research Roundup: NIAID begins new antibody trials, convalescent plasma may lower COVID-19 risk, and Pfizer vaccine appears effective against mutation

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC

Six issues to watch in US global health R&D policy in 2021

IAEA imagebank, NLO Office, Syrian Arab Republic

January 5, 2021

Six issues to watch in US global health R&D policy in 2021

2021 is shaping up to be an extraordinarily consequential year for US policy for global health and medical research, as a new presidential administration and Congress take charge against the backdrop of a global pandemic that has killed 1.6 million people worldwide and set back decades of progress in global health. As 2021 begins, here are some of the top policy issues GHTC will be tracking.

Marissa Chmiola GHTC

Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval

PATH/Rocky Prajapati

January 4, 2021

Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC

Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

From the Breakthroughs Blog: Page #3

Research Roundup: FDA approves monthly injectable HIV treatment, US recommits to WHO and joins COVAX, and Eli Lilly says antibody can prevent COVID-19 infection

Quiz: Test your knowledge of NTD innovation

Research Roundup: J&J releases interim vaccine data, African Union secures 270 million vaccine doses, and experts affirm need for next-generation vaccines

Research Roundup: NIAID begins new antibody trials, convalescent plasma may lower COVID-19 risk, and Pfizer vaccine appears effective against mutation

Six issues to watch in US global health R&D policy in 2021

Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval